Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

Beyond the breakthrough for RAS-driven cancers

Nature Medicine, Published online: 15 September 2026; doi:10.1038/s41591-026-04610-4 Two early clinical studies of selective KRASG12D inhibitors show encouraging activity in advanced cancers with G12D mutations, signaling a transformative change in the treatment landscape for RAS-driven cancers with potential applications across tumor types and stages of disease.

We haven't written up this one. Nature Medicine has the full story — the link below goes straight to it.

Read the original at nature.com →

More in Health & Medicine

DIPHTHERIA CRISIS: THE IMMUNISATION GAP

PAT ONUKWULI argues for surveillance and a catch-up vaccination in schools and communities An earlier article, “Nigeria’s Immunisation Gap,” warned that vaccine availability must not be mistaken for…

More from Tuesday 15 September →